<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00517101</url>
  </required_header>
  <id_info>
    <org_study_id>TAMSC-07-VA-318-CTIL</org_study_id>
    <nct_id>NCT00517101</nct_id>
  </id_info>
  <brief_title>Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A relationship between IBD and spondyloarthropathy is well recognized. ASCA ( anti&#xD;
      saccharomyces cerevisiae antibodies)are considered to be a serological marker for Crohn's&#xD;
      disease and have been studied in patients with spondyloarthropathy with conflicting results.&#xD;
      More recently, new serological markers for IBD have been described. These markers are&#xD;
      antibodies to certain defined glycans , and their use may permit an improved diagnosis of&#xD;
      IBD.&#xD;
&#xD;
      The aim of our study is to investigate wether these new serological markers are present in&#xD;
      the sera of patients with spondyloarthropathy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2007</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <condition>Psoriatic Arthritis</condition>
  <condition>Ankylosing Spondylitis</condition>
  <condition>Undifferentiated Spondyloarthropathy</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosis of psoriatic arthritis, ankylosing spondylitis, or undifferentiated&#xD;
             spondyloarthropathy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diagnosed inflammatory bowel disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>valerie aloush, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel-Aviv Sourasky Medical Center</affiliation>
  </overall_official>
  <verification_date>August 2007</verification_date>
  <study_first_submitted>August 15, 2007</study_first_submitted>
  <study_first_submitted_qc>August 15, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2007</study_first_posted>
  <last_update_submitted>August 15, 2007</last_update_submitted>
  <last_update_submitted_qc>August 15, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 16, 2007</last_update_posted>
  <keyword>spondyloarthropathy</keyword>
  <keyword>inflammatory bowel disease</keyword>
  <keyword>antibodies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylitis</mesh_term>
    <mesh_term>Arthritis, Psoriatic</mesh_term>
    <mesh_term>Spondylitis, Ankylosing</mesh_term>
    <mesh_term>Spondylarthropathies</mesh_term>
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

